![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/22 | |
A61K 9/20 | |||
A61K 38/21 | |||
A61K 47/34 |
(11) | Number of the document | 2552422 |
(13) | Kind of document | T |
(96) | European patent application number | 11763095.4 |
Date of filing the European patent application | 2011-04-04 | |
(97) | Date of publication of the European application | 2013-02-06 |
(45) | Date of publication and mention of the grant of the patent | 2017-09-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/KR2011/002335 |
Date | 2011-04-04 |
(87) | Number | WO 2011/122923 |
Date | 2011-10-06 |
(30) | Number | Date | Country code |
20100030577 | 2010-04-02 | KR |
(72) |
KIM, Dae Jin, KR
KIM, Min Young, KR
KIM, Jin Sun, KR
HONG, Sung Hee, KR
JUNG, Sung Youb, KR
KWON, Se Chang, KR
|
(73) |
Hanmi Science Co., Ltd.,
550 Dongtangiheung-ro Dongtan-myeon Hwaseong-si, Gyeonggi-do 445-813,
KR
|
(54) | LONG-ACTING INTERFERON BETA FORMULATION USING IMMUNOGLOBULIN FRAGMENT |
LONG-ACTING INTERFERON BETA FORMULATION USING IMMUNOGLOBULIN FRAGMENT |